BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23021045)

  • 1. Cytogenetic and mutational analyses of melanocytic tumors.
    Gerami P; Busam KJ
    Dermatol Clin; 2012 Oct; 30(4):555-66, v. PubMed ID: 23021045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferative nodules arising within congenital melanocytic nevi: a histologic, immunohistochemical, and molecular analyses of 43 cases.
    Phadke PA; Rakheja D; Le LP; Selim MA; Kapur P; Davis A; Mihm MC; Hoang MP
    Am J Surg Pathol; 2011 May; 35(5):656-69. PubMed ID: 21436676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
    Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
    Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic mutations in melanomas and benign melanocytic nevi of the female genital tract.
    Tseng D; Kim J; Warrick A; Nelson D; Pukay M; Beadling C; Heinrich M; Selim MA; Corless CL; Nelson K
    J Am Acad Dermatol; 2014 Aug; 71(2):229-36. PubMed ID: 24842760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAS and RAF mutations in banal melanocytic aggregates contiguous with primary cutaneous melanoma: clues to melanomagenesis.
    Dadzie OE; Yang S; Emley A; Keady M; Bhawan J; Mahalingam M
    Br J Dermatol; 2009 Feb; 160(2):368-75. PubMed ID: 18945298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanocytic lesions, Spitz tumors, and Don Ferrante's logic.
    Urso C
    Am J Dermatopathol; 2007 Oct; 29(5):491-4. PubMed ID: 17890925
    [No Abstract]   [Full Text] [Related]  

  • 7. Lack of oncogenic GNAQ mutations in melanocytic lesions of the conjunctiva as compared to uveal melanoma.
    Dratviman-Storobinsky O; Cohen Y; Frenkel S; Pe'er J; Goldenberg-Cohen N
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6180-2. PubMed ID: 20631239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular diagnostic contribution in melanocytic lesions analysis (FISH/CGH)].
    de la Fouchardière A; Vergier B
    Ann Pathol; 2011 Nov; 31(5 Suppl):S115-6. PubMed ID: 22054446
    [No Abstract]   [Full Text] [Related]  

  • 9. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool.
    Bauer J; Bastian BC
    Dermatol Ther; 2006; 19(1):40-9. PubMed ID: 16405569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation stability in primary and metastatic melanoma: what we know and what we don't.
    Varada S; Mahalingam M
    Histol Histopathol; 2015 Jul; 30(7):763-70. PubMed ID: 25585249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Massively parallel sequencing analysis of benign melanocytic naevi.
    Lozada JR; Geyer FC; Selenica P; Brown D; Alemar B; Merghoub T; Berger MF; Busam KJ; Halpern AC; Weigelt B; Reis-Filho JS; Hollmann TJ
    Histopathology; 2019 Jul; 75(1):29-38. PubMed ID: 30791119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical and molecular pathology of ocular uveal melanocytoma: evidence for somatic GNAQ mutations.
    Mudhar HS; Doherty R; Salawu A; Sisley K; Rennie IG
    Br J Ophthalmol; 2013 Jul; 97(7):924-8. PubMed ID: 23685997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-RAF and melanocytic neoplasia.
    Gill M; Celebi JT
    J Am Acad Dermatol; 2005 Jul; 53(1):108-14. PubMed ID: 15965430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive melanoma in an infant with congenital melanocytic nevus syndrome and multiple, NRAS and BRAF mutation-negative nodules.
    de la Rosa Carrillo D; Vindenes H; Kinsler VA; Rønnestad A; Ringstad G; Müller LO; Tafjord S; Tønseth KA; Kvamme B; Clausen OPF
    Pediatr Dermatol; 2018 Sep; 35(5):e281-e285. PubMed ID: 29999207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF and NRAS mutations in melanoma and melanocytic nevi.
    Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB
    Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Immunohistochemistry for PRAME With Cytogenetic Test Results in the Evaluation of Challenging Melanocytic Tumors.
    Lezcano C; Jungbluth AA; Busam KJ
    Am J Surg Pathol; 2020 Jul; 44(7):893-900. PubMed ID: 32317605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic melanoma in association with a giant congenital melanocytic nevus in an adult: controversial CGH findings.
    Machan S; Molina-Ruiz AM; Fernández-Aceñero MJ; Encabo B; LeBoit P; Bastian BC; Requena L
    Am J Dermatopathol; 2015 Jun; 37(6):487-94. PubMed ID: 25062263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma.
    Takata M; Murata H; Saida T
    Pigment Cell Melanoma Res; 2010 Feb; 23(1):64-71. PubMed ID: 19788535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequencies of KIT and GNAQ mutations in acral melanoma.
    Puntervoll HE; Molven A; Akslen LA
    J Cutan Pathol; 2014 Nov; 41(11):893-4. PubMed ID: 25363280
    [No Abstract]   [Full Text] [Related]  

  • 20. Somatic driver mutations in melanoma.
    Reddy BY; Miller DM; Tsao H
    Cancer; 2017 Jun; 123(S11):2104-2117. PubMed ID: 28543693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.